Igor Astsaturov

7.8k total citations
97 papers, 2.7k citations indexed

About

Igor Astsaturov is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Igor Astsaturov has authored 97 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Oncology, 28 papers in Molecular Biology and 25 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Igor Astsaturov's work include Pancreatic and Hepatic Oncology Research (16 papers), Lung Cancer Treatments and Mutations (14 papers) and Cancer-related Molecular Pathways (12 papers). Igor Astsaturov is often cited by papers focused on Pancreatic and Hepatic Oncology Research (16 papers), Lung Cancer Treatments and Mutations (14 papers) and Cancer-related Molecular Pathways (12 papers). Igor Astsaturov collaborates with scholars based in United States, Russia and Canada. Igor Astsaturov's co-authors include Erica A. Golemis, Ilya G. Serebriiskii, Linara Gabitova, Anna S. Nikonova, Roland L. Dunbrack, Andrey Gorin, Barbara Burtness, Steven J. Cohen, Crystal S. Denlinger and Paul M. Harari and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and The EMBO Journal.

In The Last Decade

Igor Astsaturov

94 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Igor Astsaturov United States 32 1.2k 1.1k 512 496 411 97 2.7k
Yoshitaka Hippo Japan 27 2.1k 1.7× 892 0.8× 681 1.3× 278 0.6× 383 0.9× 64 3.3k
Hans Morreau Netherlands 33 1.7k 1.4× 1.5k 1.3× 835 1.6× 455 0.9× 482 1.2× 77 3.9k
Hiroaki Itamochi Japan 36 1.8k 1.5× 1.1k 1.0× 649 1.3× 313 0.6× 467 1.1× 139 3.6k
Eric Santoni‐Rugiu Denmark 35 1.7k 1.4× 1.2k 1.0× 681 1.3× 757 1.5× 524 1.3× 108 3.3k
Parthasarathy Seshacharyulu United States 29 1.7k 1.4× 1.1k 1.0× 595 1.2× 421 0.8× 191 0.5× 53 2.9k
Edgar Selzer Austria 35 1.7k 1.4× 951 0.8× 525 1.0× 360 0.7× 400 1.0× 106 3.7k
Anita Mangia Italy 29 1.4k 1.1× 1.2k 1.0× 797 1.6× 407 0.8× 188 0.5× 108 2.7k
Ru Chen United States 31 1.7k 1.4× 1.2k 1.0× 673 1.3× 187 0.4× 477 1.2× 78 3.1k
Masaya Ono Japan 34 2.0k 1.6× 645 0.6× 458 0.9× 345 0.7× 228 0.6× 76 3.0k
Young Kyung Bae South Korea 26 1.1k 0.9× 944 0.8× 691 1.3× 320 0.6× 331 0.8× 122 2.5k

Countries citing papers authored by Igor Astsaturov

Since Specialization
Citations

This map shows the geographic impact of Igor Astsaturov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Astsaturov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Astsaturov more than expected).

Fields of papers citing papers by Igor Astsaturov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Igor Astsaturov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Astsaturov. The network helps show where Igor Astsaturov may publish in the future.

Co-authorship network of co-authors of Igor Astsaturov

This figure shows the co-authorship network connecting the top 25 collaborators of Igor Astsaturov. A scholar is included among the top collaborators of Igor Astsaturov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Igor Astsaturov. Igor Astsaturov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sridharan, Anush, Efrat Dotan, Mengying Deng, et al.. (2025). Racial/Ethnic Differences and Effects of Clinical/Socioeconomic Factors on Time from Diagnosis to Treatment in Pancreatic Cancer. Journal of Gastrointestinal Cancer. 56(1). 67–67. 1 indexed citations
2.
Saiman, Yedidya, et al.. (2025). Overeating: A Conundrum of Lipid Metabolism and Inflammation in Obesity and Cancer. Journal of Cellular Physiology. 240(10). e70104–e70104.
3.
Handorf, Elizabeth A., Igor Astsaturov, Michael J. Hall, et al.. (2024). Food Insecurity and Dietary Quality in African American Patients with Gastrointestinal Cancers: An Exploratory Study. Nutrients. 16(18). 3057–3057. 1 indexed citations
4.
Sorice, Kristen A., Shannon M. Lynch, Edna Cukierman, et al.. (2023). Effects of losartan and vitamin D on outcomes in metastatic pancreatic adenocarcinoma.. Journal of Clinical Oncology. 41(4_suppl). 723–723.
5.
Restifo, Diana, Dusica Cvetković, Charline Ogier, et al.. (2023). Conditional Dependency of LP-184 on Prostaglandin Reductase 1 is Synthetic Lethal in Pancreatic Cancers with DNA Damage Repair Deficiencies. Molecular Cancer Therapeutics. 22(10). 1182–1190. 2 indexed citations
6.
Hooper, Robert, Dhanendra Tomar, Parkson Lee‐Gau Chong, et al.. (2022). Suppression of Ca 2+ signaling enhances melanoma progression. The EMBO Journal. 41(19). e110046–e110046. 12 indexed citations
7.
Cho, Christina, Jinyun Chen, Farima Zahedi, et al.. (2022). Tumor-Suppressive and Immune-Stimulating Roles of Cholesterol 25-hydroxylase in Pancreatic Cancer Cells. Molecular Cancer Research. 21(3). 228–239. 15 indexed citations
8.
Dotan, Efrat, Dana B. Cardin, Heinz‐Josef Lenz, et al.. (2020). Phase Ib Study of Wnt Inhibitor Ipafricept with Gemcitabine and nab-paclitaxel in Patients with Previously Untreated Stage IV Pancreatic Cancer. Clinical Cancer Research. 26(20). 5348–5357. 59 indexed citations
9.
Gordon, Renata E., Li Zhang, Suraj Peri, et al.. (2018). Statins Synergize with Hedgehog Pathway Inhibitors for Treatment of Medulloblastoma. Clinical Cancer Research. 24(6). 1375–1388. 53 indexed citations
10.
Gerson, James N., et al.. (2017). Perspectives of HER2-targeting in gastric and esophageal cancer. Expert Opinion on Investigational Drugs. 26(5). 531–540. 74 indexed citations
11.
Beck, Tim N., Elena Shagisultanova, Elizabeth A. Handorf, et al.. (2016). EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck Cancer. Molecular Cancer Therapeutics. 15(10). 2486–2497. 44 indexed citations
12.
Zhou, Yan, S. E. Lysenko, Linara Gabitova, et al.. (2016). Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies ERCC3–MYC Interactions as a Target in Pancreatic Cancer. Clinical Cancer Research. 22(24). 6153–6163. 47 indexed citations
13.
Dotan, Efrat, R. Katherine Alpaugh, Karen Ruth, et al.. (2016). Prognostic Significance of MUC-1 in Circulating Tumor Cells in Patients With Metastatic Pancreatic Adenocarcinoma. Pancreas. 45(8). 1131–1135. 41 indexed citations
14.
Proia, David A., Donald L. Smith, Junyi Zhang, et al.. (2015). HSP90 Inhibitor–SN-38 Conjugate Strategy for Targeted Delivery of Topoisomerase I Inhibitor to Tumors. Molecular Cancer Therapeutics. 14(11). 2422–2432. 29 indexed citations
15.
Liu, Hanqing, Ilya G. Serebriiskii, Shane W. O’Brien, et al.. (2013). Network Analysis Identifies an HSP90-Central Hub Susceptible in Ovarian Cancer. Clinical Cancer Research. 19(18). 5053–5067. 41 indexed citations
16.
Khazak, Vladimir, Igor Astsaturov, Ilya G. Serebriiskii, & Erica A. Golemis. (2007). Selective Raf inhibition in cancer therapy. Expert Opinion on Therapeutic Targets. 11(12). 1587–1609. 58 indexed citations
17.
Astsaturov, Igor, Roger E. Cohen, & Paul M. Harari. (2007). EGFR-Targeting Monoclonal Antibodies in Head and Neck Cancer. Current Cancer Drug Targets. 7(7). 650–665. 25 indexed citations
18.
Winer, Shawn, Igor Astsaturov, Roger Gaedigk, et al.. (2002). ICA69null Nonobese Diabetic Mice Develop Diabetes, but Resist Disease Acceleration by Cyclophosphamide. The Journal of Immunology. 168(1). 475–482. 26 indexed citations
19.
Winer, Shawn, Igor Astsaturov, Roy K. Cheung, et al.. (2001). T Cells of Multiple Sclerosis Patients Target a Common Environmental Peptide that Causes Encephalitis in Mice. The Journal of Immunology. 166(7). 4751–4756. 39 indexed citations
20.
Winer, Shawn, Igor Astsaturov, Roy K. Cheung, et al.. (2001). Type I Diabetes and Multiple Sclerosis Patients Target Islet Plus Central Nervous System Autoantigens; Nonimmunized Nonobese Diabetic Mice Can Develop Autoimmune Encephalitis. The Journal of Immunology. 166(4). 2831–2841. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshitaka Hippo Breakdown of academic impact, for papers by Hans Morreau Breakdown of academic impact, for papers by Hiroaki Itamochi Breakdown of academic impact, for papers by Eric Santoni‐Rugiu Breakdown of academic impact, for papers by Parthasarathy Seshacharyulu Breakdown of academic impact, for papers by Edgar Selzer Breakdown of academic impact, for papers by Anita Mangia Breakdown of academic impact, for papers by Ru Chen Breakdown of academic impact, for papers by Masaya Ono Breakdown of academic impact, for papers by Young Kyung Bae
Rankless by CCL
2026